Desmosine: The Rationale for Its Use as a Biomarker of Therapeutic Efficacy in the Treatment of Pulmonary Emphysema
Desmosine and isodesmosine (DID) are elastin-specific crosslinking amino acids that play a critical role in maintaining the structural integrity of elastic fibers, and their levels in body fluids may serve as biomarkers for alveolar wall injury. To support this concept, we present studies demonstrat...
Saved in:
| Main Author: | Jerome Cantor |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Diagnostics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4418/15/5/578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Competitive Interaction of Alveolar Wall Distention with Elastin Crosslinking: A Mechanistic Approach to Emergent Phenomena in Pulmonary Emphysema
by: Jerome Cantor
Published: (2025-05-01) -
Elastin Peptides as a Potential Disease Vector in the Pathogenesis of Pulmonary Emphysema: An Investigation of This Hypothesis
by: Jerome Cantor
Published: (2025-02-01) -
Occurrence of Emphysema in Individuals With Williams-Beuren SyndromeTake-home Points
by: Uddalak Majumdar, MD, et al.
Published: (2025-03-01) -
Case Report: Contrasting outcomes and use of desmosine to monitor two patients treated with plasma cell-directed chemotherapy for gammopathy-driven pulmonary elastolysis in acquired cutis laxa
by: Lydia Lee, et al.
Published: (2025-06-01) -
Rheumatoid arthritis presenting by combined pulmonary fibrosis and emphysema with clubbing and pulmonary hypertension: A rare case report
by: Reza Basiri, et al.
Published: (2024-11-01)